AKT1 and invasive breast carcinoma: Finally, we found, in a univariate analysis of 1105 samples of breast invasive cancer from TCGA, that patients that carry mutations that increase abundance of AKT1 mRNA level have a better outcome than patients with mutations at the level of AKT2, who have shorter overall survival.